Inovio Pharmaceuticals competitors

Inovio Pharmaceuticals Competitors include Aimmune Therapeutics, Flex Pharma, Genprex and AcelRx Pharmaceuticals.
Add company...
Inovio Pharmaceuticals
Inovio Pharmaceuticals is a clinical-stage pharmaceutical company, which is involved in developing deoxyribonucleic acid immunotherapies and vaccines.
Aimmune Therapeutics
Aimmune Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a therapeutic approach, including the development of product candidates, for the treatment of peanut and other food allergies.
Flex Pharma
Flex Pharma, Inc. develops clinically proven products and treatments for muscle cramps and spasms.
Genprex
Genprex is a biopharmaceutical company developing molecular therapies for the treatment of cancer.
AcelRx Pharmaceuticals
AcelRx Pharmaceuticals is engaged in the development and commercialization of therapies for the treatment of pain and other conditions.
Founding Date
Founding Date
1979
Founding Date
2011
Founding Date
2014
Founding Date
2009
Founding Date
2005
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Blue Bell, US HQ
San Diego, US
San Diego, US
Locations
Brisbane, US HQ
Greater London, GB
Locations
Boston, US HQ
Locations
Austin, US HQ
Locations
Redwood City, US HQ
Employees
Employees
239
Employees
12220% increase
Employees
30
Employees
8
Employees
39
Valuation ($)
Valuation ($)
505.1 m
Valuation ($)
1.6 b
Valuation ($)
11.4 m
Valuation ($)
26.8 m
Valuation ($)
251.5 m
Facebook likes
Facebook likes
265
Facebook likes
N/A
Facebook likes
2.1 k
Facebook likes
N/A
Facebook likes
10
Twitter followers
Twitter followers
7 k
Twitter followers
577
Twitter followers
479
Twitter followers
10.2 k
Twitter followers
N/A

Financial

Revenue (est.)
Revenue (est.)
$42.2m (FY, 2017)
Revenue (est.)
N/A
Revenue (est.)
$1.3m (FY, 2017)
Revenue (est.)
N/A
Revenue (est.)
$8m (FY, 2017)
Net income
Net income
($88.2m) (FY, 2017)
Net income
($80.8m) (FY, 2016)
Net income
($34.4m) (FY, 2017)
Net income
($3.3m) (FY, 2017)
Net income
($51.5m) (FY, 2017)

Operating

Patents Issued
Patents Issued
620 (FY, 2016)
Patents Issued
2 (FY, 2016)
Patents Issued
N/A
Patents Issued
30 (Q2, 2017)
Patents Issued
N/A

Funding

Total funding raised
Total funding raised
$ 63.3m
Total funding raised
$ 145m
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 24.8m
For sources of this data, please see the company profileDownload Excel

View company profiles

Aimmune Therapeutics
HQ
Brisbane, US
Employees
122↑ 20% increase

Aimmune Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a therapeutic approach, including the development of product candidates, for the treatment of peanut and other food allergies.

View company
Flex Pharma
HQ
Boston, US
Employees
30

Flex Pharma, Inc. develops clinically proven products and treatments for muscle cramps and spasms.

View company
Genprex
HQ
Austin, US
Employees
8

Genprex is a biopharmaceutical company developing molecular therapies for the treatment of cancer.

View company
AcelRx Pharmaceuticals
HQ
Redwood City, US
Employees
39

AcelRx Pharmaceuticals is engaged in the development and commercialization of therapies for the treatment of pain and other conditions.

View company